SCHEMBL17899534

SCHEMBL17899534

CC(C)N1C/C(=C\c2ccc(Cl)c(Cl)c2)C(=O)/C(=C/c2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MAPT P10636 1/20 0.56
HTT P42858 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
ALDH1A1 P00352 3/20 0.53
MITF O75030 1/20 0.53
LMNA P02545 1/20 0.53
RAB9A P51151 1/20 0.53
PAX8 Q06710 2/20 0.46
HSP90AA1 P07900 1/20 0.46
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
EGFR P00533 2/20 0.44
PTK2 Q05397 2/20 0.44
IGF1R P08069 1/20 0.42
MAPK1 P28482 1/20 0.42
NAT1 P18440 1/20 0.40
ACHE P22303 1/20 0.39
CARM1 Q86X55 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899558 0.83 ACHE (0.54) SMN1; SMN2KDM4EMAPTHTTALDH1A1
SCHEMBL31686223 0.82 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL31518802 0.80 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL17899580 0.79 MAPT (0.59) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL31518790 0.78 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL22550768 0.78 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL22550785 0.77 MAPT (0.67) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL31518781 0.77 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL17899494 0.77 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EMAPTHTTNPSR1
SCHEMBL31518799 0.77 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EMAPTHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer BAYLOR COLLEGE OF MEDICINE (US) 2022-04-26 US disclosed
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2021-04-22 US disclosed
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2020-12-29 US disclosed
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents BAYLOR COLLEGE OF MEDICINE (US) 2020-03-05 US disclosed
WO-2016109470-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER BAYLOR COLLEGE OF MEDICINE (US) 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents NCOA3, FABP3, NCOA1 SMN1; SMN2 3684/4885KDM4E 2797/4885MAPT 4809/4885
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer NCOA2, NCOA1, NCOA3 SMN1; SMN2 4722/4885KDM4E 3062/4885MAPT 4834/4885
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 SMN1; SMN2 3684/4885KDM4E 2797/4885MAPT 4809/4885
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 SMN1; SMN2 3684/4885KDM4E 2797/4885MAPT 4809/4885
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 SMN1; SMN2 3684/4885KDM4E 2797/4885MAPT 4809/4885
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 SMN1; SMN2 3684/4885KDM4E 2797/4885MAPT 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.